drug
as of 2026-07-01Second Generation Long-Acting Injectable Antipsychotic Medications
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Centre for Addiction and Mental Health
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Risk of Breakthrough Symptoms With Long-Acting Injectable Medications
NCT05473741—Completed
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here